Sema4 Partners with Connecticut to Launch High-Capacity Covid-19 Testing
Sema4 is processing samples in its clinical laboratory, which can analyze 6,000 covid-19 tests per week and return results within 24 to 48 hours.
Read MorePosted by | Apr 13, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Sema4 is processing samples in its clinical laboratory, which can analyze 6,000 covid-19 tests per week and return results within 24 to 48 hours.
Read MorePosted by | Apr 13, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
Performance Insight can now populate all the required covid-19 testing data directly into the assigned template and automatically email it to HHS and FEMA.
Read MorePosted by | Apr 13, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The shared goal is to deliver high-purity, recombinant proteins for the development of covid-19 diagnostics and vaccines.
Read MorePosted by | Apr 13, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
The ANSI portal now includes 36 international standards covering medical equipment and devices.
Read MorePosted by | Apr 10, 2020 | Blood Banking, Covid 19, Emerging & Zoonotic Diseases, Hematology & Serology, Infectious Diseases |
Based on recently completed studies and epidemiologic data, FDA has concluded that current policies regarding certain donor eligibility criteria can be modified without compromising the safety of the blood supply.
Read More